CPTx
CPTx is a biotechnology company pioneering in vivo production of genetic therapies using single-stranded DNA (ssDNA) technology. Their therapies are designed to be safe, effective, and accessible for treating diseases like cancer, autoimmune disorders, and genetic conditions. CPTx utilizes proprietary ssDNA fabrication and AI-supported molecular design, with a focus on in vivo CAR-T platforms and a self-delivering gene carrier technology. The company has developed unique manufacturing processes and infrastructure for industrial-scale ssDNA synthesis, positioning them to deliver advanced therapies. CPTx was founded in 2021 and has offices in Germany and the United States, leveraging over 15 years of foundational research.
CPTx
CPTx is a biotechnology company pioneering in vivo production of genetic therapies using single-stranded DNA (ssDNA) technology. Their therapies are designed to be safe, effective, and accessible for treating diseases like cancer, autoimmune disorders, and genetic conditions. CPTx utilizes proprietary ssDNA fabrication and AI-supported molecular design, with a focus on in vivo CAR-T platforms and a self-delivering gene carrier technology. The company has developed unique manufacturing processes and infrastructure for industrial-scale ssDNA synthesis, positioning them to deliver advanced therapies. CPTx was founded in 2021 and has offices in Germany and the United States, leveraging over 15 years of foundational research.